Video Shorts
0:44
Looming DSCSA Enforcement
a year ago
by
Nicholas Jacobus(+1 more)
0:53
Transitioning from COO to CEO
a year ago
by
Mike Hollan(+1 more)
0:59
Obesity Medication's Unique Marketing Environment
a year ago
by
Mike Hollan
1:06
AI at FDA
a year ago
by
Mike Hollan
0:59
Preparing for Tariffs
a year ago
by
Mike Hollan
0:34
Federated Data Networks
a year ago
by
Mike Hollan
0:47
The Breakthrough of Multiomics
a year ago
by
Mike Hollan
1:01
Regulatory Uncertainty
a year ago
by
Mike Hollan
Advertisement
Advertisement
Trending on PharmExec
1
Hims & Hers Partners with Eli Lilly to Sell Obesity Medicines
2
Pharmaceutical Executive Daily: FDA Grants Accelerated Approval to Rybrevant Faspro
3
The US Drug-Pricing Reset: Competing on Net Value
4
Roundup: Boehringer Ingelheim Licenses Six Oncology Programs From Sino Biopharmaceutical, Nxera Licenses EP4 Agonist to AbbVie
5